Risk of hepatocellular carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis
Self-injection or administered Dose Range 2.5 mg - 15 mg Targets GLP-1 Agonist Most Common Side Effects Nausea, vomiting, diarrhea, constipation Weight Loss Efficacy 20% average body weight lost Indications BMI 30 or greater BMI 27+ with one or more weight related health issues Type 2 Diabetes Out-of-Pocket Cost (Branded) $1,000 - $1,200 USD According to GoodRx Frequently Asked Questions Top 10 Questions About Semaglutide Treatment at Bloom Semaglutide is a medication approved for weight loss, mimicking a hormone that targets areas in the brain responsible for hunger and fullness
Any product marketed as an OTC GLP-1 is likely unregulated and potentially dangerous
It was the first FDA-approved GLP-1
So, health professionals wondered: Could these drugs also be the key to curbing excess drinking
For more insights on weight management and related health strategies, visit this comprehensive guide on weight management